uniQure NV (0EE0.L)

Healthcare | Medical Pharmaceuticals
Income Statement (Quarterly) 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue 5,262,000 1,567,000 5,221,000 2,287,000
Cost of Revenue 656,000 197,000 619,000 1,021,000
Gross Profit 4,606,000 1,370,000 4,602,000 1,266,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 13,500,000 10,908,000 9,403,000 11,575,000
Operating Expenses 48,883,000 40,701,000 50,430,000 41,494,000
Operating Income -43,865,000 -39,331,000 -45,828,000 -40,228,000
Interest Expense 15,591,000 15,109,000 14,876,000 16,611,000
Income Before Tax -37,294,000 -43,141,000 -72,405,000 -44,409,000
Income Tax Expense -425,000 -496,000 856,000 -31,000
Net Income -37,719,000 -43,637,000 -73,261,000 -44,378,000
Per Share
EPS -0.69 -0.82 -1.50 -0.91
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2024-12-31 2023-12-31 2022-12-31
Revenue 27,119,000 15,843,000 106,483,000
Cost of Revenue 18,327,000 13,628,000 11,880,000
Gross Profit 8,792,000 2,215,000 94,603,000
Operating Expenses
R&D Expenses 0 0 0
SG&A Expenses 52,657,000 74,591,000 46,522,000
Operating Expenses 196,439,000 285,086,000 237,032,000
Operating Income -184,294,000 -282,871,000 -142,429,000
Interest Expense 63,741,000 41,557,000 11,704,000
Income Before Tax -237,127,000 -306,557,000 -128,259,000
Income Tax Expense 2,429,000 1,921,000 -1,470,000
Net Income -239,556,000 -308,478,000 -126,789,000
Per Share
EPS -4.92 -6.47 -2.71
EPS Diluted 0.00 0.00 0.00
Balance Sheet (Quarterly) 2024-12-31 2023-12-31 2022-12-31
Assets
Cash and Cash Equivalents 158,930,000 241,360,000 228,012,000
Short Term Investments 208,591,000 376,532,000 124,831,000
Net Receivables 5,881,000 4,193,000 102,376,000
Inventory 0 12,024,000 6,924,000
Total Current Assets 390,289,000 651,853,000 476,774,000
Property Plant Equipment 34,071,000 75,337,000 83,258,000
Goodwill and Intangibles 93,457,000 86,860,000 84,359,000
Total Assets 556,536,000 831,689,000 704,964,000
Liabilities
Account Payables 7,227,000 6,586,000 10,984,000
Short Term Debt 7,202,000 8,344,000 8,382,000
Total Current Liabilities 40,053,000 73,675,000 75,919,000
Long Term Debt 62,460,000 130,065,000 102,791,000
Total Liabilities 563,288,000 624,019,000 228,955,000
Shareholders Equity
Retained Earnings -1,129,965,000 -890,409,000 -581,931,000
Total Shareholders Equity -6,752,000 207,670,000 476,009,000
Balance Sheet (Annual) 2024-12-31 2023-12-31 2022-12-31
Assets
Cash and Cash Equivalents 158,930,000 241,360,000 228,012,000
Short Term Investments 208,591,000 376,532,000 124,831,000
Net Receivables 5,881,000 4,193,000 102,376,000
Inventory 0 12,024,000 6,924,000
Total Current Assets 390,289,000 651,853,000 476,774,000
Property Plant Equipment 34,071,000 75,337,000 83,258,000
Goodwill and Intangibles 93,457,000 86,860,000 84,359,000
Total Assets 556,536,000 831,689,000 704,964,000
Liabilities
Account Payables 7,227,000 6,586,000 10,984,000
Short Term Debt 7,202,000 8,344,000 8,382,000
Total Current Liabilities 40,053,000 73,675,000 75,919,000
Long Term Debt 62,460,000 130,065,000 102,791,000
Total Liabilities 563,288,000 624,019,000 228,955,000
Shareholders Equity
Retained Earnings -1,129,965,000 -890,409,000 -581,931,000
Total Shareholders Equity -6,752,000 207,670,000 476,009,000
Cash Flow Statement (Quarterly) 2024-12-31 2023-12-31 2022-12-31
Operating Activities
Net Income -239,556,000 -308,478,000 -126,789,000
Depreciation & Amortization 12,641,000 11,900,000 8,537,000
Stock Based Compensation 22,258,000 35,093,000 34,204,000
Change in Working Capital -3,944,000 81,123,000 -43,384,000
Operating Cash Flow -182,728,000 -145,929,000 -145,060,000
Investing Activities
Capital Expenditure -3,368,000 -7,154,000 -17,688,000
Investments -11,689,000 -7,154,000 -17,688,000
Investing Cash Flow 162,968,000 -205,686,000 -182,734,000
Financing Activities
Debt Repayment -53,050,000 0 0
Common Stock Issued/Repurchased 2,123,000 308,000 1,445,000
Dividends Paid 0 0 0
Financing Cash Flow -59,486,000 362,721,000 1,445,000
Summary
Free Cash Flow -186,096,000 -153,083,000 -162,748,000
Net Change in Cash -84,215,000 13,371,000 -328,244,000
Cash Flow Statement (Annual) 2024-12-31 2023-12-31 2022-12-31
Operating Activities
Net Income -239,556,000 -308,478,000 -126,789,000
Depreciation & Amortization 12,641,000 11,900,000 8,537,000
Stock Based Compensation 22,258,000 35,093,000 34,204,000
Change in Working Capital -3,944,000 81,123,000 -43,384,000
Operating Cash Flow -182,728,000 -145,929,000 -145,060,000
Investing Activities
Capital Expenditure -3,368,000 -7,154,000 -17,688,000
Investments -11,689,000 -7,154,000 -17,688,000
Investing Cash Flow 162,968,000 -205,686,000 -182,734,000
Financing Activities
Debt Repayment -53,050,000 0 0
Common Stock Issued/Repurchased 2,123,000 308,000 1,445,000
Dividends Paid 0 0 0
Financing Cash Flow -59,486,000 362,721,000 1,445,000
Summary
Free Cash Flow -186,096,000 -153,083,000 -162,748,000
Net Change in Cash -84,215,000 13,371,000 -328,244,000